OncoSec Medical Incorporated
Símbolo: ONCS
NASDAQ
0.2772
USDPrecio de mercado actual
-0.0457
Ratio PER
-0.0010
Ratio PEG
1.65M
Capitalización MRK
- 0.00%
Rendimiento DIV
OncoSec Medical Incorporated (ONCS) Estados Financieros
Balance de situación
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 41.19 | 12.3 | 46 | 20.4 | |||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.net-receivables | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.other-current-assets | 10.25 | 2.9 | 3.2 | 2.5 | |||||||||||||||
balance-sheet.row.total-current-assets | 51.44 | 15.2 | 49.2 | 22.8 | |||||||||||||||
balance-sheet.row.property-plant-equipment-net | 17.97 | 5.6 | 6.4 | 6.8 | |||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.intangible-assets | 1.48 | 0.4 | 0.4 | 0 | |||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 1.48 | 0.4 | 0.4 | 0 | |||||||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.other-non-current-assets | 2.29 | 0.6 | 0.3 | 0.3 | |||||||||||||||
balance-sheet.row.total-non-current-assets | 21.74 | 6.6 | 7.1 | 7.1 | |||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-assets | 73.18 | 21.9 | 56.3 | 29.9 | |||||||||||||||
balance-sheet.row.account-payables | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.short-term-debt | 6.22 | 2 | 2.1 | 1.5 | |||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.long-term-debt-total | 14.19 | 4.1 | 5.2 | 6.4 | |||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||
balance-sheet.row.other-current-liab | 19.24 | 4.6 | 5.9 | 8.2 | |||||||||||||||
balance-sheet.row.total-non-current-liabilities | 34.19 | 9.1 | 10.2 | 6.4 | |||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.capital-lease-obligations | 16.39 | 5.2 | 6.1 | 6.4 | |||||||||||||||
balance-sheet.row.total-liab | 59.65 | 15.8 | 18.2 | 16 | |||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.common-stock | 0.01 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.retained-earnings | -1158.6 | -286 | -251.8 | -206.6 | |||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 1.48 | 0.2 | -0.1 | 0 | |||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 1170.65 | 291.8 | 289.9 | 220.5 | |||||||||||||||
balance-sheet.row.total-stockholders-equity | 13.54 | 6.1 | 38.1 | 13.9 | |||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 73.18 | 21.9 | 56.3 | 29.9 | |||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-equity | 13.54 | 6.1 | 38.1 | 13.9 | |||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 73.18 | - | - | - | |||||||||||||||
Total Investments | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-debt | 20.41 | 6.2 | 7.3 | 7.8 | |||||||||||||||
balance-sheet.row.net-debt | -20.78 | -6.1 | -38.6 | -12.5 |
Estado de tesorería
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -29.39 | -34.2 | -45.2 | -42.3 | |||||||||||||||
cash-flows.row.depreciation-and-amortization | 0.94 | 1.1 | 1.1 | 1 | |||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | -0.8 | -0.1 | |||||||||||||||
cash-flows.row.stock-based-compensation | 1.28 | 1.6 | 5.1 | 3.5 | |||||||||||||||
cash-flows.row.change-in-working-capital | 2.05 | -1.2 | -2.5 | 3.8 | |||||||||||||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.inventory | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.account-payables | -1.38 | -1.4 | -2.6 | 3.6 | |||||||||||||||
cash-flows.row.other-working-capital | 3.43 | 0.2 | 0.1 | 0.2 | |||||||||||||||
cash-flows.row.other-non-cash-items | 0.12 | 0.6 | 0.5 | 0.9 | |||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -24.99 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -0.24 | -0.2 | -0.8 | 0 | |||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -0.26 | -0.2 | -0.8 | 0 | |||||||||||||||
cash-flows.row.debt-repayment | -1.15 | -1.3 | -0.6 | -0.1 | |||||||||||||||
cash-flows.row.common-stock-issued | 0.04 | 0 | 62.8 | 30 | |||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.other-financing-activites | 4.65 | 0.1 | 6 | -1.5 | |||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 3.54 | -1.2 | 68.2 | 28.4 | |||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -0.08 | -0.1 | 0 | 0 | |||||||||||||||
cash-flows.row.net-change-in-cash | -21.55 | -33.7 | 25.6 | -4.8 | |||||||||||||||
cash-flows.row.cash-at-end-of-period | 41.19 | 12.3 | 46 | 20.4 | |||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 62.74 | 46 | 20.4 | 25.1 | |||||||||||||||
cash-flows.row.operating-cash-flow | -24.99 | -32.1 | -41.8 | -33.1 | |||||||||||||||
cash-flows.row.capital-expenditure | -0.24 | -0.2 | -0.8 | 0 | |||||||||||||||
cash-flows.row.free-cash-flow | -25.24 | -32.4 | -42.6 | -33.1 |
Fila de la Cuenta de Resultados
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.gross-profit | 0 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.research-development | 21.77 | - | - | - | |||||||||||||||
income-statement-row.row.selling-general-administrative | 10.88 | - | - | - | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||
income-statement-row.row.other-expenses | 0.06 | 0 | 0 | 0.2 | |||||||||||||||
income-statement-row.row.operating-expenses | 32.65 | 37 | 48.4 | 43.4 | |||||||||||||||
income-statement-row.row.cost-and-expenses | 32.65 | 37 | 48.4 | 43.4 | |||||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.interest-expense | 0.05 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||
income-statement-row.row.total-other-income-expensenet | -0.07 | -0.5 | 0.8 | 0.3 | |||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||
income-statement-row.row.other-operating-expenses | 0.06 | 0 | 0 | 0.2 | |||||||||||||||
income-statement-row.row.total-operating-expenses | -0.07 | -0.5 | 0.8 | 0.3 | |||||||||||||||
income-statement-row.row.interest-expense | 0.05 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0.99 | 1.1 | 1.1 | 1.2 | |||||||||||||||
income-statement-row.row.ebitda-caps | -31.66 | - | - | - | |||||||||||||||
income-statement-row.row.operating-income | -32.65 | -37 | -48.4 | -43.4 | |||||||||||||||
income-statement-row.row.income-before-tax | -32.72 | -37.5 | -47.6 | -43.1 | |||||||||||||||
income-statement-row.row.income-tax-expense | -2.58 | -3.3 | -2.4 | -0.9 | |||||||||||||||
income-statement-row.row.net-income | -30.14 | -34.2 | -45.2 | -42.3 |
Preguntas frecuentes
Cuánto es OncoSec Medical Incorporated (ONCS) activos totales?
OncoSec Medical Incorporated (ONCS) los activos totales son 21878368.000.
¿Cuáles son los ingresos anuales de la empresa?
Los ingresos anuales son N/A.
¿Cuál es el margen de beneficios de la empresa?
El margen de beneficios de la empresa es 0.000.
¿Qué es el flujo de caja libre de la empresa?
El flujo de caja libre es -4.923.
¿Cuál es el margen de beneficio neto de la empresa?
El margen de beneficio neto es 0.000.
¿Cuáles son los ingresos totales de la empresa?
Los ingresos totales son 0.000.
¿Qué es OncoSec Medical Incorporated (ONCS) beneficio neto (ingresos netos)?
El beneficio neto (ingresos netos) es -34179634.000.
¿Cuál es la deuda total de la empresa?
La deuda total es 6174765.000.
¿Cuál es la cifra de gastos de explotación?
Los gastos de explotación son 37012062.000.
¿Cuál es la cifra de tesorería de la empresa?
La tesorería de la empresa es 3683330.000.